Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation

Busulfan is an alkylating drug routinely used in conditioning regimens for allogeneic hematopoietic cell transplantation (allo-HCT). A myeloablative conditioning regimen, including busulfan, is commonly used in patients undergoing T-cell depletion (TCD) and allo-HCT, but data on optimal busulfan pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamari, Roni, Scordo, Michael, Kunvarjee, Binni M., Proli, Anthony, Lin, Andrew, Flynn, Jessica, Cho, Christina, Devlin, Sean, Klein, Elizabeth, Boulad, Farid, Cancio, Maria I., Curran, Kevin J., Jakubowski, Ann A., Kernan, Nancy A., Kung, Andrew L., O’Reilly, Richard J., Papadopoulos, Esperanza B., Prockop, Susan, Scaradavou, Andromachi, Shaffer, Brian C., Shah, Gunjan, Spitzer, Barbara, Gyurkocza, Boglarka, Giralt, Sergio A., Perales, Miguel-Angel, Boelens, Jaap Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Hematopoiesis and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500467/
https://www.ncbi.nlm.nih.gov/pubmed/37379285
http://dx.doi.org/10.1182/bloodadvances.2023009708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500467/
https://www.ncbi.nlm.nih.gov/pubmed/37379285
http://dx.doi.org/10.1182/bloodadvances.2023009708

Ejemplares similares